Ayala Pharmaceuticals Inc (AYLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,001 | 372 | 845 | 852 | 265 |
| Cost of Goods | 1,001 | 375 | 485 | 160 | 265 |
| Gross Profit | N/A | -3 | 360 | 692 | N/A |
| Operating Expenses | 6,440 | 5,758 | 5,802 | 4,620 | 3,865 |
| Operating Income | -6,439 | -5,386 | -4,957 | -3,768 | -3,600 |
| Other Income | -38 | 42 | -51 | 98 | 136 |
| Pre-tax Income | -6,477 | -5,344 | -5,008 | -3,670 | -3,464 |
| Income Tax | 121 | 79 | 39 | 113 | 75 |
| Net Income Continuous | -6,598 | -5,423 | -5,047 | -3,783 | -3,539 |
| Net Income | $-6,598 | $-5,423 | $-5,047 | $-3,783 | $-3,539 |
| EPS Basic Total Ops | -1.32 | -1.09 | -1.01 | -0.76 | -0.71 |
| EPS Basic Continuous Ops | -1.32 | -1.08 | -1.01 | -0.76 | -0.71 |
| EPS Diluted Total Ops | -1.32 | -1.09 | -1.01 | -0.76 | -0.71 |
| EPS Diluted Continuous Ops | -1.32 | -1.08 | -1.01 | -0.76 | -0.71 |
| EBITDA(a) | $-6,386 | $-5,283 | $-4,938 | $-3,760 | $-3,580 |